Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study

BACKGROUND: Type 1 retinopathy of prematurity (ROP) is occasionally observed in preterm infants after the postmenstrual age (PMA) of 40 weeks; however, evidence-based treatment guidelines are largely lacking. In this study, we report the clinical characteristics of preterm infants with type 1 ROP at...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Jiao, Zhang, Qi, Chen, Chunli, Xu, Yu, Ji, Xunda, Zhao, Peiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390561/
https://www.ncbi.nlm.nih.gov/pubmed/30808338
http://dx.doi.org/10.1186/s12886-019-1067-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390561/
https://www.ncbi.nlm.nih.gov/pubmed/30808338
http://dx.doi.org/10.1186/s12886-019-1067-4

Ejemplares similares